Oropouche Virus Test Introduced by Quest Diagnostics
Quest Diagnostics has launched a new PCR-based diagnostic test for the Oropouche virus, enhancing preparedness for this emerging disease.
Quest Diagnostics has launched a new PCR-based diagnostic test for the Oropouche virus, enhancing preparedness for this emerging disease.
AI-enhanced EEG technology offers a promising, accessible way to detect early signs of Alzheimer’s disease—years before symptoms appear.
Scopio Labs has received its fourth FDA clearance for enhanced decision support features in its X100 and X100HT platforms.
LG AI Research has launched EXAONE Path 2.0, a cutting-edge precision medical AI model that predicts gene mutations and biological markers.
QuidelOrtho and BÜHLMANN Laboratories have partnered to launch the fCAL turbo and fPELA turbo fecal biomarker assays on VITROS Systems.